Annual Net Income
$19.66 M
+$59.08 M+149.87%
December 31, 2021
Summary
- As of February 10, 2025, LJPC annual net profit is $19.66 million, with the most recent change of +$59.08 million (+149.87%) on December 31, 2021.
- During the last 3 years, LJPC annual net income has risen by +$219.13 million (+109.86%).
Performance
LJPC Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Net Income
$2.46 M
+$2.46 M+122800.00%
June 30, 2022
Summary
- As of February 10, 2025, LJPC quarterly net profit is $2.46 million, with the most recent change of +$2.46 million (+122800.00%) on June 30, 2022.
- Over the past year, LJPC quarterly net income has dropped by -$1.27 million (-34.15%).
Performance
LJPC Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM Net Income
$3.97 M
-$1.27 M-24.31%
June 30, 2022
Summary
- As of February 10, 2025, LJPC TTM net profit is $3.97 million, with the most recent change of -$1.27 million (-24.31%) on June 30, 2022.
- Over the past year, LJPC TTM net income has increased by +$1.06 million (+36.25%).
Performance
LJPC TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
LJPC Net Income Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +149.9% | -34.1% | +36.3% |
3 y3 years | +109.9% | +108.1% | +103.4% |
5 y5 years | +117.1% | +109.2% | +103.4% |
LJPC Net Income Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | at low | -34.8% | -99.9% | -79.8% | at low |
5 y | 5-year | at high | -692.6% | -83.0% | -1126.6% | -79.8% | -3035.4% |
alltime | all time | at high | -1114.6% | -83.0% | -2247.2% | -79.8% | -5125.7% |
La Jolla Pharmaceutical Net Income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2022 | - | $2.46 M(>+9900.0%) | $3.97 M(-24.3%) |
Mar 2022 | - | $2000.00(-99.9%) | $5.24 M(-73.3%) |
Dec 2021 | $19.66 M(-149.9%) | $3.77 M(-266.8%) | $19.66 M(+58.4%) |
Sep 2021 | - | -$2.26 M(-160.5%) | $12.41 M(+326.1%) |
Jun 2021 | - | $3.73 M(-74.1%) | $2.91 M(-117.7%) |
Mar 2021 | - | $14.42 M(-514.5%) | -$16.41 M(-58.4%) |
Dec 2020 | -$39.42 M(-66.2%) | -$3.48 M(-70.4%) | -$39.42 M(-35.6%) |
Sep 2020 | - | -$11.76 M(-24.6%) | -$61.18 M(-22.2%) |
Jun 2020 | - | -$15.59 M(+81.5%) | -$78.59 M(-15.9%) |
Mar 2020 | - | -$8.59 M(-66.0%) | -$93.41 M(-19.8%) |
Dec 2019 | -$116.51 M(-41.6%) | -$25.23 M(-13.5%) | -$116.51 M(-14.8%) |
Sep 2019 | - | -$29.17 M(-4.1%) | -$136.69 M(-13.6%) |
Jun 2019 | - | -$30.42 M(-4.0%) | -$158.26 M(-12.4%) |
Mar 2019 | - | -$31.68 M(-30.2%) | -$180.63 M(-9.4%) |
Dec 2018 | -$199.47 M(+73.7%) | -$45.42 M(-10.5%) | -$199.47 M(+3.6%) |
Sep 2018 | - | -$50.74 M(-3.9%) | -$192.60 M(+14.5%) |
Jun 2018 | - | -$52.78 M(+4.5%) | -$168.14 M(+18.3%) |
Mar 2018 | - | -$50.53 M(+31.1%) | -$142.09 M(+23.8%) |
Dec 2017 | -$114.80 M(+46.8%) | -$38.55 M(+46.6%) | -$114.80 M(+13.5%) |
Sep 2017 | - | -$26.29 M(-1.6%) | -$101.14 M(+5.2%) |
Jun 2017 | - | -$26.73 M(+15.0%) | -$96.11 M(+13.1%) |
Mar 2017 | - | -$23.24 M(-6.6%) | -$84.94 M(+8.6%) |
Dec 2016 | -$78.19 M(+86.5%) | -$24.89 M(+17.1%) | -$78.19 M(+20.0%) |
Sep 2016 | - | -$21.25 M(+36.5%) | -$65.13 M(+19.8%) |
Jun 2016 | - | -$15.57 M(-5.6%) | -$54.35 M(+9.9%) |
Mar 2016 | - | -$16.48 M(+39.3%) | -$49.44 M(+18.0%) |
Dec 2015 | -$41.91 M(+96.6%) | -$11.83 M(+13.0%) | -$41.91 M(+13.5%) |
Sep 2015 | - | -$10.47 M(-1.7%) | -$36.93 M(+17.2%) |
Jun 2015 | - | -$10.65 M(+18.9%) | -$31.51 M(+25.3%) |
Mar 2015 | - | -$8.96 M(+30.7%) | -$25.14 M(+18.0%) |
Dec 2014 | -$21.31 M(+18.8%) | -$6.85 M(+35.6%) | -$21.31 M(+2.2%) |
Sep 2014 | - | -$5.05 M(+17.9%) | -$20.86 M(+4.4%) |
Jun 2014 | - | -$4.28 M(-16.5%) | -$19.98 M(+5.9%) |
Mar 2014 | - | -$5.13 M(-19.8%) | -$18.86 M(+5.2%) |
Dec 2013 | -$17.93 M(+131.8%) | -$6.40 M(+53.3%) | -$17.93 M(+22.5%) |
Sep 2013 | - | -$4.17 M(+31.9%) | -$14.64 M(+15.4%) |
Jun 2013 | - | -$3.16 M(-24.8%) | -$12.69 M(-26.3%) |
Mar 2013 | - | -$4.20 M(+35.3%) | -$17.23 M(+122.6%) |
Dec 2012 | -$7.74 M(-33.0%) | -$3.10 M(+39.7%) | -$7.74 M(-56.9%) |
Sep 2012 | - | -$2.22 M(-71.1%) | -$17.96 M(+47.6%) |
Jun 2012 | - | -$7.70 M(-245.7%) | -$12.17 M(-5065.7%) |
Mar 2012 | - | $5.28 M(-139.7%) | $245.00 K(-102.1%) |
Dec 2011 | -$11.55 M(+207.1%) | -$13.32 M(-473.2%) | -$11.55 M(-471.6%) |
Sep 2011 | - | $3.57 M(-24.3%) | $3.11 M(-554.4%) |
Jun 2011 | - | $4.71 M(-172.4%) | -$684.00 K(-92.0%) |
Mar 2011 | - | -$6.51 M(-588.3%) | -$8.50 M(+126.1%) |
Dec 2010 | -$3.76 M(-56.5%) | $1.33 M(-700.5%) | -$3.76 M(-44.2%) |
Sep 2010 | - | -$222.00 K(-92.8%) | -$6.73 M(-6.6%) |
Jun 2010 | - | -$3.10 M(+75.7%) | -$7.21 M(+17.3%) |
Mar 2010 | - | -$1.77 M(+7.7%) | -$6.15 M(-28.8%) |
Dec 2009 | -$8.63 M(-86.3%) | -$1.64 M(+135.1%) | -$8.63 M(-64.2%) |
Sep 2009 | - | -$698.00 K(-65.8%) | -$24.14 M(-40.5%) |
Jun 2009 | - | -$2.04 M(-52.0%) | -$40.58 M(-24.1%) |
Mar 2009 | - | -$4.25 M(-75.2%) | -$53.47 M(-14.9%) |
Dec 2008 | -$62.85 M | -$17.15 M(+0.1%) | -$62.85 M(+4.6%) |
Sep 2008 | - | -$17.13 M(+14.7%) | -$60.11 M(+6.8%) |
Jun 2008 | - | -$14.94 M(+9.5%) | -$56.26 M(+2.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2008 | - | -$13.64 M(-5.3%) | -$54.84 M(+3.3%) |
Dec 2007 | -$53.08 M(+34.6%) | -$14.40 M(+8.4%) | -$53.08 M(+7.5%) |
Sep 2007 | - | -$13.29 M(-1.7%) | -$49.37 M(+10.6%) |
Jun 2007 | - | -$13.52 M(+13.9%) | -$44.62 M(+10.3%) |
Mar 2007 | - | -$11.87 M(+11.0%) | -$40.45 M(+2.5%) |
Dec 2006 | -$39.45 M(+44.2%) | -$10.69 M(+25.3%) | -$39.45 M(+13.4%) |
Sep 2006 | - | -$8.54 M(-8.6%) | -$34.79 M(+8.1%) |
Jun 2006 | - | -$9.35 M(-14.0%) | -$32.18 M(+10.6%) |
Mar 2006 | - | -$10.87 M(+79.9%) | -$29.09 M(+6.3%) |
Dec 2005 | -$27.36 M(-32.5%) | -$6.04 M(+1.9%) | -$27.36 M(-15.3%) |
Sep 2005 | - | -$5.93 M(-5.2%) | -$32.29 M(-17.6%) |
Jun 2005 | - | -$6.25 M(-31.6%) | -$39.20 M(-5.1%) |
Mar 2005 | - | -$9.14 M(-16.7%) | -$41.31 M(+1.9%) |
Dec 2004 | -$40.54 M(+4.4%) | -$10.97 M(-14.5%) | -$40.54 M(+6.7%) |
Sep 2004 | - | -$12.83 M(+53.3%) | -$38.02 M(+18.4%) |
Jun 2004 | - | -$8.37 M(-0.1%) | -$32.12 M(-4.6%) |
Mar 2004 | - | -$8.38 M(-0.8%) | -$33.67 M(-13.3%) |
Dec 2003 | -$38.84 M(-10.3%) | -$8.44 M(+21.7%) | -$38.84 M(-10.8%) |
Sep 2003 | - | -$6.93 M(-30.1%) | -$43.56 M(-7.9%) |
Jun 2003 | - | -$9.92 M(-26.7%) | -$47.31 M(-2.9%) |
Mar 2003 | - | -$13.54 M(+2.9%) | -$48.74 M(+12.5%) |
Dec 2002 | -$43.32 M(+75.5%) | -$13.16 M(+23.1%) | -$43.32 M(+17.6%) |
Sep 2002 | - | -$10.69 M(-5.9%) | -$36.84 M(+17.0%) |
Jun 2002 | - | -$11.36 M(+40.0%) | -$31.50 M(+20.0%) |
Mar 2002 | - | -$8.12 M(+21.4%) | -$26.25 M(+6.3%) |
Dec 2001 | -$24.68 M(+78.9%) | -$6.68 M(+25.0%) | -$24.68 M(+13.7%) |
Sep 2001 | - | -$5.35 M(-12.4%) | -$21.71 M(+5.5%) |
Jun 2001 | - | -$6.11 M(-6.8%) | -$20.58 M(+17.8%) |
Mar 2001 | - | -$6.55 M(+76.8%) | -$17.47 M(+26.6%) |
Dec 2000 | -$13.80 M(+50.8%) | -$3.71 M(-12.2%) | -$13.80 M(+10.0%) |
Sep 2000 | - | -$4.22 M(+41.0%) | -$12.54 M(+20.4%) |
Jun 2000 | - | -$2.99 M(+4.1%) | -$10.42 M(+5.0%) |
Mar 2000 | - | -$2.88 M(+17.5%) | -$9.93 M(+8.5%) |
Dec 1999 | -$9.15 M(+15.8%) | -$2.45 M(+16.6%) | -$9.15 M(+6.4%) |
Sep 1999 | - | -$2.10 M(-16.0%) | -$8.60 M(+2.4%) |
Jun 1999 | - | -$2.50 M(+19.0%) | -$8.40 M(+5.0%) |
Mar 1999 | - | -$2.10 M(+10.5%) | -$8.00 M(+1.3%) |
Dec 1998 | -$7.90 M(+23.4%) | -$1.90 M(0.0%) | -$7.90 M(0.0%) |
Sep 1998 | - | -$1.90 M(-9.5%) | -$7.90 M(+2.6%) |
Jun 1998 | - | -$2.10 M(+5.0%) | -$7.70 M(+6.9%) |
Mar 1998 | - | -$2.00 M(+5.3%) | -$7.20 M(+12.5%) |
Dec 1997 | -$6.40 M(-33.3%) | -$1.90 M(+11.8%) | -$6.40 M(+23.1%) |
Sep 1997 | - | -$1.70 M(+6.3%) | -$5.20 M(-21.2%) |
Jun 1997 | - | -$1.60 M(+33.3%) | -$6.60 M(-16.5%) |
Mar 1997 | - | -$1.20 M(+71.4%) | -$7.90 M(-17.7%) |
Dec 1996 | -$9.60 M(+11.6%) | -$700.00 K(-77.4%) | -$9.60 M(-20.7%) |
Sep 1996 | - | -$3.10 M(+6.9%) | -$12.10 M(+30.1%) |
Jun 1996 | - | -$2.90 M(0.0%) | -$9.30 M(+2.2%) |
Mar 1996 | - | -$2.90 M(-9.4%) | -$9.10 M(+5.8%) |
Dec 1995 | -$8.60 M(-16.5%) | -$3.20 M(+966.7%) | -$8.60 M(+14.7%) |
Sep 1995 | - | -$300.00 K(-88.9%) | -$7.50 M(-21.1%) |
Jun 1995 | - | -$2.70 M(+12.5%) | -$9.50 M(-1.0%) |
Mar 1995 | - | -$2.40 M(+14.3%) | -$9.60 M(-6.8%) |
Dec 1994 | -$10.30 M | -$2.10 M(-8.7%) | -$10.30 M(+25.6%) |
Sep 1994 | - | -$2.30 M(-17.9%) | -$8.20 M(+39.0%) |
Jun 1994 | - | -$2.80 M(-9.7%) | -$5.90 M(+90.3%) |
Mar 1994 | - | -$3.10 M | -$3.10 M |
FAQ
- What is La Jolla Pharmaceutical annual net profit?
- What is the all time high annual net income for La Jolla Pharmaceutical?
- What is La Jolla Pharmaceutical annual net income year-on-year change?
- What is La Jolla Pharmaceutical quarterly net profit?
- What is the all time high quarterly net income for La Jolla Pharmaceutical?
- What is La Jolla Pharmaceutical quarterly net income year-on-year change?
- What is La Jolla Pharmaceutical TTM net profit?
- What is the all time high TTM net income for La Jolla Pharmaceutical?
- What is La Jolla Pharmaceutical TTM net income year-on-year change?
What is La Jolla Pharmaceutical annual net profit?
The current annual net income of LJPC is $19.66 M
What is the all time high annual net income for La Jolla Pharmaceutical?
La Jolla Pharmaceutical all-time high annual net profit is $19.66 M
What is La Jolla Pharmaceutical annual net income year-on-year change?
Over the past year, LJPC annual net profit has changed by +$59.08 M (+149.87%)
What is La Jolla Pharmaceutical quarterly net profit?
The current quarterly net income of LJPC is $2.46 M
What is the all time high quarterly net income for La Jolla Pharmaceutical?
La Jolla Pharmaceutical all-time high quarterly net profit is $14.42 M
What is La Jolla Pharmaceutical quarterly net income year-on-year change?
Over the past year, LJPC quarterly net profit has changed by -$1.27 M (-34.15%)
What is La Jolla Pharmaceutical TTM net profit?
The current TTM net income of LJPC is $3.97 M
What is the all time high TTM net income for La Jolla Pharmaceutical?
La Jolla Pharmaceutical all-time high TTM net profit is $19.66 M
What is La Jolla Pharmaceutical TTM net income year-on-year change?
Over the past year, LJPC TTM net profit has changed by +$1.06 M (+36.25%)